BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 30594196)

  • 1. PAX6 Promoter Methylation Correlates with MDA-MB-231 Cell Migration, and Expression of MMP2 and MMP9.
    Urrutia G; Laurito S; Campoy E; Nasif D; Branham MT; Roqué M
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2859-2866. PubMed ID: 30362313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of Oncogenic Long Non-coding RNAs in Cancer Development.
    Do H; Kim W
    Genomics Inform; 2018 Dec; 16(4):e18. PubMed ID: 30602079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis.
    Altaf R; Ilyas U; Ma A; Shi M
    Front Oncol; 2023; 13():1206768. PubMed ID: 37324026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of germline variants in the metastasis of breast carcinomas.
    Santonja Á; Moya-García AA; Ribelles N; Jiménez-Rodríguez B; Pajares B; Fernández-De Sousa CE; Pérez-Ruiz E; Del Monte-Millán M; Ruiz-Borrego M; de la Haba J; Sánchez-Rovira P; Romero A; González-Neira A; Lluch A; Alba E
    Oncotarget; 2022; 13():843-862. PubMed ID: 35782051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted Article: Long non-coding RNA MEG3 inhibits cell proliferation, migration, invasion and enhances apoptosis in non-small cell lung cancer cells by regulating the miR-31-5p/TIMP3 axis.
    Li K; Wang X; Huang Z; Xu H; Zheng S; Qiu Y
    RSC Adv; 2019 Nov; 9(65):38200-38208. PubMed ID: 35541776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAB26 contributes to the progression of non-small cell lung cancer after being transcriptionally activated by SMAD3.
    Ren H; Yang B; Li M; Lu C; Li X
    Bioengineered; 2022 Apr; 13(4):8064-8075. PubMed ID: 35291909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic PAX6 elicits CDK4/6 inhibitor resistance by epigenetically inactivating the LATS2-Hippo signaling pathway.
    Zhang Y; He LJ; Huang LL; Yao S; Lin N; Li P; Xu HW; Wu XW; Xu JL; Lu Y; Li YJ; Zhu SL
    Clin Transl Med; 2021 Aug; 11(8):e503. PubMed ID: 34459131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA DUXAP10 Upregulation and the Hedgehog Pathway Activation Are Critically Involved in Chronic Cadmium Exposure-Induced Cancer Stem Cell-Like Property.
    Lin HP; Wang Z; Yang C
    Toxicol Sci; 2021 Oct; 184(1):33-45. PubMed ID: 34373904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGR1 and RXRA transcription factors link TGF-β pathway and CCL2 expression in triple negative breast cancer cells.
    Gorbacheva AM; Uvarova AN; Ustiugova AS; Bhattacharyya A; Korneev KV; Kuprash DV; Mitkin NA
    Sci Rep; 2021 Jul; 11(1):14120. PubMed ID: 34239022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated TCGA and GEO analysis showed that SMAD7 is an independent prognostic factor for lung adenocarcinoma.
    Dai ZT; Wang J; Zhao K; Xiang Y; Li JP; Zhang HM; Peng ZT; Liao XH
    Medicine (Baltimore); 2020 Oct; 99(44):e22861. PubMed ID: 33126329
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Ansar M; Wang CJ; Wang YH; Shen TH; Hung CS; Chang SC; Lin RK
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMAD-6, -7 and -9 are potential molecular biomarkers for the prognosis in human lung cancer.
    Pan S; Zhou G; Hu W; Pei H
    Oncol Lett; 2020 Sep; 20(3):2633-2644. PubMed ID: 32782581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6.
    Jin M; Gao D; Wang R; Sik A; Liu K
    Oncol Rep; 2020 Aug; 44(2):555-564. PubMed ID: 32627030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of SMAD3 inhibits the growth and enhances the radiosensitivity of lung adenocarcinoma via p21
    Niu H; Huang Y; Yan L; Zhang L; Zhao M; Lu T; Yang X; Chen Z; Zhan C; Shi Y; Wang Q
    Int J Biol Sci; 2020; 16(6):1010-1022. PubMed ID: 32140069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the mechanism by which SMAD3 induces PAX6 transcription to promote the development of non-small cell lung cancer.
    Qian Z; Zhang Q; Hu Y; Zhang T; Li J; Liu Z; Zheng H; Gao Y; Jia W; Hu A; Li B; Hao J
    Respir Res; 2018 Dec; 19(1):262. PubMed ID: 30594196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
    Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
    Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-140's inhibition on the cell migration and invasion of non-small cell lung cancer by down-regulating Smad3 expression.
    Han P; Wang XH; Han YF; Chen GM
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9471-9479. PubMed ID: 31773685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.
    Chen H; Yang T; Lei Z; Wang L; Yang H; Tong X; Yang WT; Zhao J; Gu Y; Chen Y; Zhang HT
    Lung Cancer; 2015 Oct; 90(1):32-40. PubMed ID: 26238425
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.